Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Keystone Symposium: Innate Immunity and Determinants of Microbial Pathogenesis - joint with - Mechanisms of Pro-Inflammatory Diseases
Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci.
Siponimod (BAF312) for the Treatment of Secondary Progressive Multiple Sclerosis: Design of the Phase 3 EXPAND Trial
Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE.
Randomized study combining interferon & glatiramer acetate in multiple sclerosis.
Benefit of interferon beta-1a on MSFC progression in secondary progressive MS.
Activity-Dependent and Experience-Driven Myelination Provide New Directions for the Management of Multiple Sclerosis.
Novel MS Drugs Advance
Other National MS Societies (Not listed here)
From High- to Low-Frequency Administered Interferon-Beta for Multiple Sclerosis: A Multicenter Study.
Extraocular Source of Oligodendrocytes Contribute to Retinal Myelination and Optokinetic Responses in Zebrafish.
The Australian Multiple Sclerosis (MS) Immunotherapy Study: A Prospective, Multicentre Study of Drug Utilisation Using the MSBase Platform.
Breastfeeding and multiple sclerosis relapses: a meta-analysis.
Dimethyl fumarate for multiple sclerosis.
Synthetic Biologics announces issuance of U.S. patent covering combination of estriol and Copaxone® for multiple sclerosis
Secondary Progressive Multiple Sclerosis: Definition and Measurement.
endMS CONFERENCE
Pathogenic aquaporin-4 reactive T cells are sufficient to induce mouse model of neuromyelitis optica.
Autoantibodies and pain.
Covis Pharma to Acquire U.S. Rights from Sanofi for Nilandron®, Plaquenil®, Rilutek®, Uroxatral®, and Kayexalate®
Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosis.
Predictors of Fatigue Impact in Persons With Long-Standing Multiple Sclerosis.
Antibody to α4 integrin suppresses natural killer cells infiltration in central nervous system in experimental autoimmune encephalomyelitis.
Phase IV, Rater-blinded, Randomized Study, Comparing the Effects of 250 mg of Betaseron With 20 mg of Copaxone in Patients With the Relapsing-remitting or Clinically Isolated Forms of Multiple Sclerosis Using 3 Tesla MRI With Triple-dose Gadolinium
Sex hormones and multiple sclerosis: another informative failure.

Pages